You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human immunodeficiency virus-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1, Human Immunodeficiency Virus 1, Immunodeficiency Virus Type 1, Human Trial (MK-8510)

Not yet recruiting
  • HIV-1
  • +3 more
  • (no location specified)
Jan 17, 2023

HIV Trial (Fostemsavir)

Available
  • HIV Infections
  • (no location specified)
Jun 13, 2022

HIV Infection Trial (DOR/ISL)

Not yet recruiting
  • HIV Infection
  • (no location specified)
Mar 1, 2023

HIV-1 Trial (Doravirine, Darunavir, Ritonavir)

Active, not recruiting
Has Results
  • HIV-1
  • (no location specified)
Aug 19, 2022

Cancer in People Living With HIV/AIDS at Cancer Centers in Latin

Active, not recruiting
  • HIV Infection
  • +3 more
  • Medical Chart Review
  • Survey Administration
  • Buenos Aires, Argentina
  • +3 more
Oct 20, 2022

HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)

Completed
  • HIV-1-infection
  • BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
  • Madrid, Spain
    Hospital FUNDACIÓN JIMÉNEZ DÍAZ
Nov 2, 2022

Human Immunodeficiency Virus-1 (HIV-1) Infection Trial (HRS5685;Placebo)

Not yet recruiting
  • Human Immunodeficiency Virus-1 (HIV-1) Infection
  • HRS5685；Placebo
  • (no location specified)
Apr 6, 2022

Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)

Not yet recruiting
  • Human Immunodeficiency Virus
  • HIV
  • (no location specified)
Oct 13, 2022

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • ABT-493 coformulated with ABT-530
  • (no location specified)
Jul 9, 2021

Human Immunodeficiency Virus (HIV) Trial (Doravirine, Tenofovir, Lamivudine, ATRIPLA™, Placebo)

Active, not recruiting
Has Results
  • Human Immunodeficiency Virus (HIV)
  • Doravirine, Tenofovir, Lamivudine
  • +2 more
  • (no location specified)
Sep 1, 2022

Human Immunodeficiency Virus Type 1 Trial in Worldwide (Rilpivirine)

Recruiting
  • Human Immunodeficiency Virus Type 1
  • Brescia, Italy
  • +13 more
Jan 17, 2023

Human Immunodeficiency Virus Trial in Chicago (brentuximab vedotin, Placebo, ART)

Recruiting
  • Human Immunodeficiency Virus
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Jul 29, 2022

Human Immunodeficiency Virus I Infection, Immunodeficiency Virus Type 1, Human, Human Immunodeficiency Virus Type 1 Trial in New

Not yet recruiting
  • Human Immunodeficiency Virus I Infection
  • +2 more
  • MGD020
  • MGD014
  • (no location specified)
Jun 27, 2022

HIV I Infection Trial in United States (VIR-1111, Placebo)

Active, not recruiting
  • HIV I Infection
  • VIR-1111
  • Placebo
  • Miami, Florida
  • +3 more
Jul 22, 2022

Human Immunodeficiency Virus Trial (MK-8527)

Not yet recruiting
  • Human Immunodeficiency Virus
  • (no location specified)
Aug 8, 2022

HIV Trial in Rochester (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
    Univ. of Rochester AVEG
Oct 27, 2021

Human Immunodeficiency Virus (HIV) Trial in South Africa, Spain, United States (DRV/COBI FDC)

Recruiting
  • Human Immunodeficiency Virus (HIV)
  • DRV/COBI FDC
  • Atlanta, Georgia
  • +5 more
Aug 2, 2022

Human Immunodeficiency Virus Infections Trial in India (Rilpivirine 25 mg, Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC))

Terminated
  • Human Immunodeficiency Virus Infections
  • Rilpivirine 25 mg
  • Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC)
  • Bengaluru, India
  • +5 more
Jun 23, 2022

HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • HIV Seronegativity
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
  • +2 more
Oct 28, 2021

HIV-1 Trial in Panama, South Africa, United States (F/TAF, 3rd ARV agent, Boosted PIs)

Active, not recruiting
Has Results
  • HIV-1
  • Los Angeles, California
  • +7 more
Nov 11, 2022

HPV, Human Papilloma Virus, Human Immunodeficiency Virus Trial in Vancouver (Nonavalent HPV vaccine)

Not yet recruiting
  • HPV
  • +2 more
  • Nonavalent HPV vaccine
  • Vancouver, British Columbia, Canada
    University of British Columbia
Aug 8, 2022

Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Ad26.Mos.HIV
  • +2 more
  • Bangkok, Thailand
    (unnamed)
Dec 29, 2021

Human Immunodeficiency Virus (HIV) Infections Trial (Islatravir)

Not yet recruiting
  • Human Immunodeficiency Virus (HIV) Infections
  • (no location specified)
Jun 21, 2022

HIV-1 Infection Trial (MK-8507)

Completed
  • HIV-1 Infection
  • (no location specified)
Jul 22, 2022

HIV-1 Infection Trial (ART, DOR/ISL)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Jan 4, 2023